The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Aldeyra Therapeutics regarding its New Drug Application (NDA) for reproxalap, a novel eye drop intended for the treatment of the signs and symptoms of dry eye disease. This decision marks the third regulatory setback for the Lexington, Massachusetts-based biotechnology company […]
The healthcare industry is currently navigating a period of profound financial restructuring as stakeholders grapple with the dual pressures of rising costs and heightened consumer expectations. According to a comprehensive six-part research series commissioned by Zelis and conducted by Datos Insights, the financial dimension of healthcare has become just as critical as clinical outcomes in […]
In a significant development for the healthcare technology sector, GuardDog Telehealth has formally admitted to misrepresenting its business operations to gain unauthorized access to patient medical records. This admission marks the first major concession in a high-stakes legal battle led by Epic Systems, the nation’s largest electronic health record (EHR) vendor, against a network of […]
The pharmaceutical and biotechnology sectors are currently undergoing a fundamental transformation driven by the integration of Real-World Evidence (RWE) and Machine Learning (ML). As of late 2024, RWE has transitioned from a supplementary data source to a primary pillar of the drug development lifecycle, appearing in approximately 70 percent of all new drug and biologic […]
The annual SXSW Festival in Austin, Texas, known for its intersection of technology, culture, and business, became the backdrop for a sharp critique of the burgeoning direct-to-consumer healthcare industry. On a sweltering afternoon with temperatures exceeding 95 degrees, Mark Cuban, the billionaire co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of eMed Population Health, […]
The U.S. Food and Drug Administration (FDA) has initiated a profound shift in its regulatory framework, moving away from long-standing evidentiary requirements toward a more flexible, data-driven approach designed to accelerate the delivery of treatments for rare and life-threatening conditions. This transition was recently punctuated by the landmark approval of leucovorin calcium for cerebral folate […]
The United States is approaching a historic demographic inflection point that will fundamentally reshape its social, economic, and healthcare landscapes over the next decade. According to data from the U.S. Census Bureau, by the year 2034, approximately 20 percent of the American population will be over the age of 65. For the first time in […]
The transformative power of data-driven decision-making first captured the public imagination through the story of Billy Beane, the general manager of the Oakland Athletics who revolutionized professional baseball. As chronicled in the book and film Moneyball, Beane faced a fundamental challenge: his team could not outspend the wealthy New York Yankees or Boston Red Sox. […]
The burgeoning field of digital health has reached a pivotal milestone as new research indicates that virtual gastrointestinal (GI) solutions are not only improving patient outcomes but also generating substantial economic value for the healthcare system. According to a comprehensive assessment released by the Peterson Health Technology Institute (PHTI), digital interventions designed to manage Irritable […]
The global medical technology landscape was shaken this week as Stryker Corporation, a cornerstone of the American medtech industry, became the target of a massive cyberattack that has crippled its internal infrastructure on a worldwide scale. The incident, which began on Wednesday, has forced the multinational corporation to navigate a significant operational crisis, impacting everything […]
